Kevin Anderson is a clinical development executive who founded Avery & Riley to advise biotech companies on applied AI strategy. With a career spanning roles at Moderna, Alexion, and Amgen, he focuses on integrating AI to solve operational bottlenecks in drug development. He holds an MBA from Boston College.
Kevin is deeply involved in the broader biotech community, having served as Co-Chair of MassBios Biostats, Data Management & Clinical Trials Working Group. He also contributes to the Clinical AI Innovators Network, a community for professionals advancing AI in drug development.
His advisory firm, Avery & Riley, is named after the middle names of his two daughters, reflecting a personal standard of judgment and integrity.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.